- Home
- MTEN vs RLYB Comparison
MTEN vs RLYB Comparison
Compare MTEN & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEN
- RLYB
- Stock Information
- Founded
- MTEN 2015
- RLYB 2018
- Country
- MTEN China
- RLYB United States
- Employees
- MTEN N/A
- RLYB N/A
- Industry
- MTEN Building Products
- RLYB Biotechnology: Pharmaceutical Preparations
- Sector
- MTEN Industrials
- RLYB Health Care
- Exchange
- MTEN Nasdaq
- RLYB Nasdaq
- Market Cap
- MTEN 29.3M
- RLYB 24.1M
- IPO Year
- MTEN 2024
- RLYB 2021
- Fundamental
- Price
- MTEN $2.92
- RLYB $0.66
- Analyst Decision
- MTEN
- RLYB Hold
- Analyst Count
- MTEN 0
- RLYB 2
- Target Price
- MTEN N/A
- RLYB N/A
- AVG Volume (30 Days)
- MTEN 94.8K
- RLYB 267.0K
- Earning Date
- MTEN 10-01-2025
- RLYB 11-07-2025
- Dividend Yield
- MTEN N/A
- RLYB N/A
- EPS Growth
- MTEN N/A
- RLYB N/A
- EPS
- MTEN N/A
- RLYB N/A
- Revenue
- MTEN $10,735,337.00
- RLYB $761,000.00
- Revenue This Year
- MTEN N/A
- RLYB N/A
- Revenue Next Year
- MTEN N/A
- RLYB N/A
- P/E Ratio
- MTEN N/A
- RLYB N/A
- Revenue Growth
- MTEN 16.63
- RLYB 154.51
- 52 Week Low
- MTEN $2.40
- RLYB $0.22
- 52 Week High
- MTEN $26.03
- RLYB $1.24
- Technical
- Relative Strength Index (RSI)
- MTEN 25.93
- RLYB 61.87
- Support Level
- MTEN $2.40
- RLYB $0.54
- Resistance Level
- MTEN $5.80
- RLYB $0.72
- Average True Range (ATR)
- MTEN 0.81
- RLYB 0.05
- MACD
- MTEN 0.06
- RLYB 0.01
- Stochastic Oscillator
- MTEN 15.03
- RLYB 70.26
About MTEN Mingteng International Corporation Inc. Ordinary Shares
Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides an extensive product lineup including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in the automobile, construction machinery, and other manufacturing industries.
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.